Neuberger Berman Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-470,900	Closed	-$25.2M	–	1759
2020 Q4	$25.2M	Buy	470,900 +92,800	+25%	+$4.61M	0.03%	574
2020 Q3	$15.6M	Buy	378,100 +160,000	+73%	+$6.91M	0.02%	636
2020 Q2	$10.6M	Buy	218,100 +165,000	+311%	+$7.92M	0.01%	703
2020 Q1	$2.24M	Buy	53,100 +13,000	+32%	+$536K	﹤0.01%	922
2019 Q4	$1.72M	Buy	40,100 +13,700	+52%	+$596K	﹤0.01%	1059
2019 Q3	$950K	Buy	26,400 +2,800	+12%	+$84.9K	﹤0.01%	1162
2019 Q2	$631K	Buy	23,600 +10,600	+82%	+$271K	﹤0.01%	1247
2019 Q1	$349K	Buy	+13,000	New	+$304K	﹤0.01%	1336
2017 Q3	–	Sell	-62,664	Closed	-$1.75M	–	1596
2017 Q2	$1.75M	Buy	62,664 +29,326	+88%	+$874K	﹤0.01%	1030
2017 Q1	$1.15M	Buy	+33,338	New	+$1.18M	﹤0.01%	1120
2015 Q2	–	Sell	-391,600	Closed	-$12.8M	–	1553
2015 Q1	$12.8M	Buy	391,600 +365,800	+1,418%	+$12.6M	0.01%	791
2014 Q4	$819K	Buy	+25,800	New	+$732K	﹤0.01%	1259
2014 Q3	–	Sell	-16,325	Closed	-$369K	–	1640
2014 Q2	$369K	Sell	16,325 -27,625	-63%	-$577K	﹤0.01%	1446
2014 Q1	$1.07M	Sell	43,950 -7,985	-15%	-$202K	﹤0.01%	1203
2013 Q4	$1.3M	Buy	+51,935	New	+$1.23M	﹤0.01%	1153